Paul Faulder PhD
CEO | LinkedIn
Paul has over a decade of experience in drug discovery research within the Biotechnology and Pharmaceutical sectors working for AstraZeneca, GlaxoSmithKline, Amgen and Tularik. With over 20 patents and publications, he has engaged and collaborated with many world class scientists across multiple global projects.
Having experienced the complexities for effective communication between collaborators, he recognised the need of scientists in teams and managers, for more efficient and transparent solutions to provide greater partnering insight.
This realisation, coupled with his entrepreneurial interests, led Paul to co-found Elixir Software Limited, a company with the aim of providing high quality and cost effective IT solutions to this market.
Martin Harrison PhD
SOFTWARE DIRECTOR | LinkedIn
Martin has 18 years of software development experience in the Biotechnology and Pharmaceutical sectors including AstraZeneca, Amgen, Tularik, Protherics and Proteus Molecular Design.
His activities have focussed on the integration of chemoinformatics with process management to support the design – make – test – analysis cycle of the drug discovery process.
He has won numerous awards including an AstraZeneca Global Innovation Award for contributing to effective management of global drug discovery projects.
He has extensive experience in agile software development in both Scrum and Kanban environments alongside test-driven development and product owner experience.
Cresset
Cresset’s small molecule design and flexible information delivery framework is an integral component of Torx™, a complete Design-Make-Test-Analyze workflow in a single web platform, giving real-time visibility of both planned and current drug discovery projects.
Torx Software
Along with Cresset, Elixir Software is a founding development partner of Torx, a single web-based platform for small molecule discovery chemistry.